Rapid communication Open Access
Like 0


We observed a rebound in consumption of antibacterials for systemic use (ATC J01) in the community sector in the European Union/European Economic Area during 2021 and 2022, after an observed decrease between 2019 and 2020. The rates in 2022 returned to pre-COVID-19-pandemic levels and were exceeded in 13 countries. Although these patterns could partly be a result of changes in disease transmission during the study period, it could also reflect a lost opportunity to strengthen and reinforce prudent antibiotic use.


Article metrics loading...

Loading full text...

Full text loading...



  1. Högberg LD, Vlahović-Palčevski V, Pereira C, Weist K, Monnet DL, ESAC-Net study group, et al. Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020. Euro Surveill. 2021;26(46):2101020.  https://doi.org/10.2807/1560-7917.ES.2021.26.46.2101020  PMID: 34794534 
  2. European Centre for Disease Prevention and Control (ECDC). European Surveillance of Antimicrobial Consumption Network (ESAC-Net). Annual Epidemiological Report for 2021. Stockholm: ECDC; 2022. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/ESAC-Net_AER_2021_final-rev.pdf
  3. World Health Organization (WHO) Collaborating Centre (CC) for Drug Statistics Methodology. ATC/DDD Index 2023. Oslo: Norwegian Institute of Public Health (WHOCC); 2023. [Accessed: 10 Oct 2023]. Available from: https://www.whocc.no/atc_ddd_index
  4. European Centre for Disease Prevention and Control (ECDC). Antimicrobial consumption (AMC) reporting protocol 2023. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/ESACNet_protocol_2023_1.pdf
  5. Council of the European Union. Council Recommendation on stepping up EU actions to combat antimicrobial resistance in a One Health approach. 2023. Available from: https://health.ec.europa.eu/publications/council-recommendation-stepping-eu-actions-combat-antimicrobial-resistance-one-health-approach_en
  6. Nandi A, Pecetta S, Bloom DE. Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020-2022. EClinicalMedicine. 2023;57:101848.  https://doi.org/10.1016/j.eclinm.2023.101848  PMID: 36776504 
  7. Principi N, Autore G, Ramundo G, Esposito S. Epidemiology of respiratory infections during the COVID-19 pandemic. Viruses. 2023;15(5):1160.  https://doi.org/10.3390/v15051160  PMID: 37243246 
  8. Tomczyk S, Taylor A, Brown A, de Kraker MEA, El-Saed A, Alshamrani M, et al. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. J Antimicrob Chemother. 2021;76(11):3045-58.  https://doi.org/10.1093/jac/dkab300  PMID: 34473285 
  9. Lionello L, Stranges D, Karki T, Wiltshire E, Proietti C, Annunziato A, et al. Non-pharmaceutical interventions in response to the COVID-19 pandemic in 30 European countries: the ECDC-JRC Response Measures Database. Euro Surveill. 2022;27(41):2101190.  https://doi.org/10.2807/1560-7917.ES.2022.27.41.2101190  PMID: 36239171 
  10. Johannesen TB, Munkstrup C, Edslev SM, Baig S, Nielsen S, Funk T, et al. Increase in invasive group A streptococcal infections and emergence of novel, rapidly expanding sub-lineage of the virulent Streptococcus pyogenes M1 clone, Denmark, 2023. Euro Surveill. 2023;28(26):2300291.  https://doi.org/10.2807/1560-7917.ES.2023.28.26.2300291  PMID: 37382884 
  11. Lassoued Y, Assad Z, Ouldali N, Caseris M, Mariani P, Birgy A, et al. Unexpected Increase in invasive Group A streptococcal infections in children after respiratory viruses outbreak in France: a 15-year time-series analysis. Open Forum Infect Dis. 2023;10(5):ofad188.  https://doi.org/10.1093/ofid/ofad188  PMID: 37180594 
  12. De Maio F, Fiori B, Bianco DM, Sanguinetti M, Sali M. Respiratory viruses in the pre and post-pandemic periods in an Italian tertiary hospital. Immun Inflamm Dis. 2023;11(8):e909.  https://doi.org/10.1002/iid3.909  PMID: 37647421 
  13. European Centre for Disease Prevention and Control (ECDC). Seasonal influenza 2022−2023. Annual Epidemiological Report for 2023. Stockholm: ECDC; 2023. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/seasonal-influenza-annual-epidemiological-report-2022-2023.pdf
  14. Lu D. Children’s immunity at risk. New Sci. 2021;250(3332):8-9.  https://doi.org/10.1016/S0262-4079(21)00716-8  PMID: 33967369 
  15. European Centre for Disease Prevention and Control (ECDC). European Surveillance of Antimicrobial Consumption Network (ESAC-Net). Annual Epidemiological Report for 2020. Stockholm: ECDC; 2021. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/ESAC-Net%20AER-2020-Antimicrobial-consumption-in-the-EU-EEA.pdf
  16. Ghiga I, Pitchforth E, Stålsby Lundborg C, Machowska A. Family doctors’ roles and perceptions on antibiotic consumption and antibiotic resistance in Romania: a qualitative study. BMC Prim Care. 2023;24(1):93.  https://doi.org/10.1186/s12875-023-02047-z  PMID: 37038124 
  17. Bogdanić N, Močibob L, Vidović T, Soldo A, Begovac J. Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020. PLoS One. 2022;17(2):e0263437.  https://doi.org/10.1371/journal.pone.0263437  PMID: 35108332 
  18. de Lusignan S, Joy M, Sherlock J, Tripathy M, van Hecke O, Gbinigie K, et al. PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study. BJGP Open. 2021;5(5):BJGPO.2021.0087.  https://doi.org/10.3399/BJGPO.2021.0087  PMID: 34312163 
  19. Cohen R, Pettoello-Mantovani M, Giardino I, Carrasco-Sanz A, Somekh E, Levy C. The shortage of amoxicillin: an escalating public health crisis in pediatrics faced by several western countries. J Pediatr. 2023;257:113321.  https://doi.org/10.1016/j.jpeds.2023.01.001  PMID: 36669589 
  20. European Medicines Agency (EMA). Shortage of amoxicillin and amoxicillin/clavulanic acid. Amsterdam: EMA; 2023. Available from: https://www.ema.europa.eu/en/documents/shortage/amoxicillin-amoxicillin/clavulanic-acid-supply-shortage_en.pdf

Data & Media loading...

Submit comment
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error